Type I interferon signaling promotes radioresistance in head and neck cancer.
Zenga J, Awan MJ, Frei A, Massey B, Bruening J, Shukla M, Sharma GP, Shreenivas A, Wong SJ, Zimmermann MT, Mathison AJ, Himburg HA.
Zenga J, et al. Among authors: himburg ha.
Transl Cancer Res. 2024 May 31;13(5):2535-2543. doi: 10.21037/tcr-23-2104. Epub 2024 May 13.
Transl Cancer Res. 2024.
PMID: 38881922
Free PMC article.